Overview

Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer

Status:
NOT_YET_RECRUITING

Trial end date:
2026-02-01

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to learn if drug Purified Exosome Product (PEP) and Fibrin Sealant (TISSEEL VH SD Kit) (PEP-TISSEEL) works to treat chronic radiation ulcer in adults and compare it with comparator TISSEEL. It will also learn about the safety of drug PEP-TISSEEL.

Phase:

PHASE1

Details

Lead Sponsor:

Rion Inc.

Collaborators:

Henry M. Jackson Foundation for the Advancement of Military Medicine
Walter Reed National Military Medical Center